These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 28130275)

  • 1. Modulation of mTOR signaling as a strategy for the treatment of Pompe disease.
    Lim JA; Li L; Shirihai OS; Trudeau KM; Puertollano R; Raben N
    EMBO Mol Med; 2017 Mar; 9(3):353-370. PubMed ID: 28130275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic Benefit of Autophagy Modulation in Pompe Disease.
    Lim JA; Sun B; Puertollano R; Raben N
    Mol Ther; 2018 Jul; 26(7):1783-1796. PubMed ID: 29804932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Akt inactivation induces endoplasmic reticulum stress-independent autophagy in fibroblasts from patients with Pompe disease.
    Nishiyama Y; Shimada Y; Yokoi T; Kobayashi H; Higuchi T; Eto Y; Ida H; Ohashi T
    Mol Genet Metab; 2012 Nov; 107(3):490-5. PubMed ID: 23041259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pompe Disease: From Basic Science to Therapy.
    Kohler L; Puertollano R; Raben N
    Neurotherapeutics; 2018 Oct; 15(4):928-942. PubMed ID: 30117059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of autophagy in the pathogenesis of Pompe disease.
    Raben N; Roberts A; Plotz PH
    Acta Myol; 2007 Jul; 26(1):45-8. PubMed ID: 17915569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activated mTOR signaling pathway in myofibers with inherited metabolic defect might be an evidence for mTOR inhibition therapies.
    Lyu JW; Xu XB; Ji KQ; Zhang N; Sun Y; Zhao DD; Zhao YY; Yan CZ
    Chin Med J (Engl); 2019 Apr; 132(7):805-810. PubMed ID: 30897595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Galectins Control mTOR in Response to Endomembrane Damage.
    Jia J; Abudu YP; Claude-Taupin A; Gu Y; Kumar S; Choi SW; Peters R; Mudd MH; Allers L; Salemi M; Phinney B; Johansen T; Deretic V
    Mol Cell; 2018 Apr; 70(1):120-135.e8. PubMed ID: 29625033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autophagy and lysosomes in Pompe disease.
    Fukuda T; Roberts A; Ahearn M; Zaal K; Ralston E; Plotz PH; Raben N
    Autophagy; 2006; 2(4):318-20. PubMed ID: 16874053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of muscle mTOR kinase activity causes early onset myopathy and compromises whole-body homeostasis.
    Zhang Q; Duplany A; Moncollin V; Mouradian S; Goillot E; Mazelin L; Gauthier K; Streichenberger N; Angleraux C; Chen J; Ding S; Schaeffer L; Gangloff YG
    J Cachexia Sarcopenia Muscle; 2019 Feb; 10(1):35-53. PubMed ID: 30461220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cu(II) disrupts autophagy-mediated lysosomal degradation of oligomeric Aβ in microglia via mTOR-TFEB pathway.
    Tan X; Guan H; Yang Y; Luo S; Hou L; Chen H; Li J
    Toxicol Appl Pharmacol; 2020 Aug; 401():115090. PubMed ID: 32512069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MITF-MIR211 axis is a novel autophagy amplifier system during cellular stress.
    Ozturk DG; Kocak M; Akcay A; Kinoglu K; Kara E; Buyuk Y; Kazan H; Gozuacik D
    Autophagy; 2019 Mar; 15(3):375-390. PubMed ID: 30290719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cartilage-specific deletion of mTOR upregulates autophagy and protects mice from osteoarthritis.
    Zhang Y; Vasheghani F; Li YH; Blati M; Simeone K; Fahmi H; Lussier B; Roughley P; Lagares D; Pelletier JP; Martel-Pelletier J; Kapoor M
    Ann Rheum Dis; 2015 Jul; 74(7):1432-40. PubMed ID: 24651621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The new era of Pompe disease: advances in the detection, understanding of the phenotypic spectrum, pathophysiology, and management.
    Kishnani PS; Beckemeyer AA; Mendelsohn NJ
    Am J Med Genet C Semin Med Genet; 2012 Feb; 160C(1):1-7. PubMed ID: 22253049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autophagy and mistargeting of therapeutic enzyme in skeletal muscle in Pompe disease.
    Fukuda T; Ahearn M; Roberts A; Mattaliano RJ; Zaal K; Ralston E; Plotz PH; Raben N
    Mol Ther; 2006 Dec; 14(6):831-9. PubMed ID: 17008131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined aerobic exercise and enzyme replacement therapy rejuvenates the mitochondrial-lysosomal axis and alleviates autophagic blockage in Pompe disease.
    Nilsson MI; MacNeil LG; Kitaoka Y; Suri R; Young SP; Kaczor JJ; Nates NJ; Ansari MU; Wong T; Ahktar M; Brandt L; Hettinga BP; Tarnopolsky MA
    Free Radic Biol Med; 2015 Oct; 87():98-112. PubMed ID: 26001726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. mTOR Signaling in Growth, Metabolism, and Disease.
    Saxton RA; Sabatini DM
    Cell; 2017 Mar; 168(6):960-976. PubMed ID: 28283069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ability of adeno-associated virus serotype 8-mediated hepatic expression of acid alpha-glucosidase to correct the biochemical and motor function deficits of presymptomatic and symptomatic Pompe mice.
    Ziegler RJ; Bercury SD; Fidler J; Zhao MA; Foley J; Taksir TV; Ryan S; Hodges BL; Scheule RK; Shihabuddin LS; Cheng SH
    Hum Gene Ther; 2008 Jun; 19(6):609-21. PubMed ID: 18500944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mammalian target of rapamycin (mTOR) as a potential therapeutic target in various diseases.
    Kaur A; Sharma S
    Inflammopharmacology; 2017 Jun; 25(3):293-312. PubMed ID: 28417246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Roles of Mammalian Target of Rapamycin Signaling and Autophagy Pathway in Alzheimer's Disease].
    Chang YF; Hu WM
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2019 Apr; 41(2):248-255. PubMed ID: 31060682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-199a-3p is involved in estrogen-mediated autophagy through the IGF-1/mTOR pathway in osteocyte-like MLO-Y4 cells.
    Fu J; Hao L; Tian Y; Liu Y; Gu Y; Wu J
    J Cell Physiol; 2018 Mar; 233(3):2292-2303. PubMed ID: 28708244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.